http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103340878-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99a2938a5ae9b610397d080481ff2912 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
filingDate | 2013-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99790254a0a01728c3c3d5487984b239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31279cf8fde97817179bdff7e8ee3f7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397c25f1f4870ec47bd7e3ba49eb8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e06d2373f94fa0c4e7cb043c01d479 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f1b1983df493a1b9a41c64d1997009 |
publicationDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103340878-B |
titleOfInvention | Compound ofloxacin solution for veterinary use and preparation process of compound ofloxacin solution |
abstract | The invention discloses a compound ofloxacin solution for veterinary use and a preparation process of the compound ofloxacin solution. Each 1L of the compound ofloxacin solution for veterinary use consists of 3-8g of ofloxacin, 1-6g of PVP-K30, 1-6g of chlorhexidine acetate, 0.5-2g of sodium hydrogen sulfite, 10-35g of benzyl alcohol, 0.5-2g of EDTA-2Na, 0.8-2g of Tween-80, 10-200g of propylene glycol, 50-300g of glycerol and injection water for the balance. According to the compound ofloxacin solution, the chlorhexidine acetate is combined with ofloxacin which belongs to quinolone bactericidal medicines, so as to completely develop functional characteristics of the chlorhexidine acetate as a cationic surface active agent, thus changing bacterial membrane permeability, promoting the ofloxacin to enter into bacterium cells, and enhancing the antibacterial function of the ofloxacin; the ofloxacin, chlorhexidine acetate and benzyl alcohol, although are bactericidal medicines, are different in sterilizing mechanism and free from mutual antagonism, so that the bacterium is difficult to generate drug resistance on the three medicines simultaneously; the PVP-K30 can inhibit odor from spreading, and the benzyl alcohol is fragrant, so that the product has a quite strong deodorizing function. |
priorityDate | 2013-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.